This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Herlyn, D. Articles by Herlyn, M. Search for Related Content PubMed PubMed Citation Articles by Herlyn, D. Articles by Herlyn, M.

In Vitro Properties of Human Melanoma Cells Metastatic in Nude Mice¹

The Wistar Institute of Anatomy and Biology [D. H., D. I., H. H., K. A., A. H. R., J. J., H. K., M. H.]; the Department of Dermatology, University of Pennsylvania [P. J. J., J. B.]; and Children's Hospital [A. P.] Philadelphia, Pennsylvania 19104

We have developed a human melanoma metastasis model in nude mice. In this model, a human variant cell line (451-LU) was obtained that spontaneously metastasized in nude mice. This variant cell line was selected from the lung of a nude mouse after several in vivo passages of human melanoma WM164 cells previously isolated from a melanoma metastasis of a patient. The WM164 cells were not competent for metastasis in nude mice prior to this selection. We compared the phenotypes of the parental nonmetastatic cell line and the metastatic variant with respect to growth at clonal seeding densities in protein-free medium (growth factor independence), in vitro invasion through reconstructed basement membranes, secretion of proteolytic enzymes, expression of tumor-associated antigens, and chromosomal abnormalities. Metastatic 451-LU cells showed significantly increased growth factor independence when grown at clonal seeding densities as compared to the parental cells. In in vitro chemoinvasion assays, metastatic 451-LU cells were significantly more invasive than the parental cells. The metastatic variant secreted collagenase and tissue type plasminogen activator at levels 10- and 3-fold higher than the parental WM164 cells, respectively. Polyclonal antibodies to tissue type plasminogen activator significantly inhibited invasion through reconstructed basement membranes. In metastatic 451-LU cells, expression of nerve growth factor receptor was elevated, both at the protein and transcriptional level. Metastatic cells were aneuploid with a mode of 97 chromosomes, whereas the parental non-metastatic cells had a mode of 52 chromosomes.

Our studies suggest that metastatic melanoma cell variants selected in vivo show increased independence of exogenous growth factors when grown at clonal cell densities, enhanced invasiveness in vitro, greater secretion of proteolytic enzymes, and increased chromosome mode as compared to the nonmetastatic parental cells. The data further suggest that melanoma cells isolated from metastatic lesions and maintained in vitro have an unstable invasive phenotype but that metastatic variant cells can readily be selected.

¹ These studies were supported by NIH Grants CA-25874, CA-44877, CA-10815, and NS-21716.

² To whom requests for reprints should be addressed.

Received 4/ 3/89. Revised 1/ 8/90.

This article has been cited by other articles:

				I. S. Zagon, R. N. Donahue, and P. J. McLaughlin Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1154 - R1161. [Abstract] [Full Text] [PDF]

				E. Ortiz-Zapater, S. Peiro, O. Roda, J. M. Corominas, S. Aguilar, C. Ampurdanes, F. X. Real, and P. Navarro Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2 Am. J. Pathol., May 1, 2007; 170(5): 1573 - 1584. [Abstract] [Full Text] [PDF]

				J. K. L. Woodward, C. E. Nichols, I. G. Rennie, M. A. Parsons, A. K. Murray, and K. Sisley An In Vitro Assay to Assess Uveal Melanoma Invasion across Endothelial and Basement Membrane Barriers Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1708 - 1714. [Abstract] [Full Text] [PDF]

				C. Berking, R. Takemoto, H. Schaider, L. Showe, K. Satyamoorthy, P. Robbins, and M. Herlyn Transforming Growth Factor-{beta}1 Increases Survival of Human Melanoma through Stroma Remodeling Cancer Res., November 1, 2001; 61(22): 8306 - 8316. [Abstract] [Full Text] [PDF]

				U. Graeven, U. Rodeck, S. Karpinski, M. Jost, S. Philippou, and W. Schmiegel Modulation of Angiogenesis and Tumorigenicity of Human Melanocytic Cells by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Cancer Res., October 1, 2001; 61(19): 7282 - 7290. [Abstract] [Full Text] [PDF]

				K. Satyamoorthy, G. Li, B. Vaidya, D. Patel, and M. Herlyn Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and {beta}-Catenin Pathways Cancer Res., October 1, 2001; 61(19): 7318 - 7324. [Abstract] [Full Text] [PDF]

				M. Nesbit, H. Schaider, T. H. Miller, and M. Herlyn Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells J. Immunol., June 1, 2001; 166(11): 6483 - 6490. [Abstract] [Full Text] [PDF]

				F Mitjans, D Sander, J Adan, A Sutter, J. Martinez, C. Jaggle, J. Moyano, H. Kreysch, J Piulats, and S. Goodman An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice J. Cell Sci., January 8, 1995; 108(8): 2825 - 2838. [Abstract] [PDF]

				Y. Maeshima, P. C. Colorado, and R. Kalluri Two RGD-independent alpha vbeta 3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties J. Biol. Chem., July 28, 2000; 275(31): 23745 - 23750. [Abstract] [Full Text] [PDF]

				Y. Maeshima, M. Manfredi, C. Reimer, K. A. Holthaus, H. Hopfer, B. R. Chandamuri, S. Kharbanda, and R. Kalluri Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin J. Biol. Chem., April 27, 2001; 276(18): 15240 - 15248. [Abstract] [Full Text] [PDF]

				Y. Maeshima, U. L. Yerramalla, M. Dhanabal, K. A. Holthaus, S. Barbashov, S. Kharbanda, C. Reimer, M. Manfredi, W. M. Dickerson, and R. Kalluri Extracellular Matrix-derived Peptide Binds to alpha vbeta 3 Integrin and Inhibits Angiogenesis J. Biol. Chem., August 17, 2001; 276(34): 31959 - 31968. [Abstract] [Full Text] [PDF]